Medicon Valley Biomedical Newsletter

Vipergen is a biotech start-up company founded in 2005 to commercialise a new, proprietary drug discovery technology platform. Vipergen's technology platform allows isolation of high qualit...

LEO Pharma Research Foundation has granted Karsten Wessel Eriksen, M.Sc, Ph.D, Faculty of Health Sciences, University of Copenhagen, EUR 16,000 to the project; Activation and Regulation of STAT Signal...

The NeuroFortis Centre at Lund University has received EUR 2.3 million for a five-year programme from the Swedish Research Council. The programme will explore novel mechanisms of neurodegenerat...

The Swedish Foundation for Strategic Research has granted five centres in Lund EUR 21 million for a five-year period. One of the centres is located at Lund University, where Professor Patrik Rorsman a...

ALK-Abelló A/S will acquire Schering AG's 50% interest in the German sales subsidiary ALK-Scherax with a view to securing the platform for the expected launch of GRAZAX in Germany as well as to contin...

Chr. Hansen A/S, Canadian Urex Biotech Inc., and BioGaia AB have entered agreements that will allow the global distribution of a probiotic product containing a strain of Lactobacillus reuteri targetin...

BioGaia AB has signed a 5-year agreement with HSO Pharma giving the company exclusive rights to market the BioGaia dental products, tablets and baby drops in pharmacies and clinics in Austria. ...

BoneSupport AB has sold one of its families of patents to the Swiss orthopaedics company Mathys Ltd Bettlach. The invention is non-core to their business and raised a revenue of EUR 1.2 million. ...

Camurus AB has initiated a Phase I/IIa clinical study to evaluate safety, tolerability and preliminary efficacy of CAM2028, which is an oromucosal formulation of an agent being used for topical treatm...

Exiqon A/S has won the Ernst & Young Entrepreneur of the Year award in the category, Biotech 2005. The prestigious award is created to identify and acknowledge the most successful and entrepreneur...

Gastrotech Pharma A/S has announced that it has completed a private equity financing, raising a total of EUR 2.3 million. Bioscience Managers Limited, BML, investing on behalf of 123Multinova Europe, ...

LEO Pharma A/S and Israel-based Foamix Ltd. have signed an agreement to jointly develop two topical medicated foams for the treatment of psoriasis. The foams will be based on LEO Pharma's propriet...

Lundbeck has initiated phase I clinical studies with Lu AA24530 in order to investigate tolerability and the pharmacokinetic profile of the drug. Lu AA24530 was selected as a developme...

NeuroSearch A/S has initiated a clinical Phase I/II study with the AMPA antagonist NS1209 for the treatment of neuropathic pain. Necessary approvals from the authorities and the ethical committees hav...

Nycomed has announced that it has officially opened its office in Madrid, Spain. In addition to entering the Spanish market for pharmaceutical products, the creation of Nycomed Spain is an important s...

Pharmexa A/S and IDM Pharma, Inc. have entered into an agreement whereby Pharmexa will acquire certain infectious disease and other assets from IDM related to the former San Diego-based company Epimmu...

Genmab A/S has announced that its partner Roche has filed an Investigational New Drug application, IND, with the FDA for a Genmab antibody developed under the collaboration of the two compani...

Symbion Science Park in Copenhagen has received an award as the Best Science Park Incubator 2005 at an international conference in Turin, Italy Symbion Science Park in Copenhagen has r...

Copenhagen Capacity and Position Skåne will present Medicon Valley at BIO2006 Annual International Convention April 9-12 2006 in Chicago. Medicon Valley will be part of the joint Nordic booth "Sc...